Faith Howard

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (7)

Penelope Ottewell

Professor

University of Sheffield

UNITED KINGDOM

View details

Aneurin James Kennerley

Manchester Metropolitan University

UNITED KINGDOM

View details

Sanjay K. Srivastava

Texas Tech University Health Sciences Center

UNITED STATES

View details

Alan Graham Pockley

Emeritus Professor of Immunobiology

University of Nottingham

UNITED KINGDOM

View details

Magnus Essand

Professor

Uppsala University

SWEDEN

View details

Richard Allen

University of Sheffield

UNITED KINGDOM

View details

Munitta Muthana

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Faith Howard

Research Interests

Explore related searches

Contact this professor

Articles (12)

Pectin Extraction from Citrus Waste: Structural Quality and Yield with Mineral and Organic Acids

Preferred Place of Death Discussions: Are They Informing and Empowering Patients and their Family Caregivers?

Microfluidic-Assisted Silk Nanoparticles Co-Loaded with Epirubicin and Copper Sulphide: A Synergistic Photothermal–Photodynamic Chemotherapy Against Breast Cancer

Efficient and Rapid Microfluidics Production of Bio-Inspired Nanoparticles Derived from Bombyx mori Silkworm for Enhanced Breast Cancer Treatment

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Development of a personalised device for systemic magnetic drug targeting to brain tumours

Nanobugs as Drugs: Bacterial Derived Nanomagnets Enhance Tumor Targeting and Oncolytic Activity of HSV‐1 Virus

Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer

Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?

Inconsistencies in modeling the efficacy of the oncolytic virus HSV1716 reveal potential predictive biomarkers for tolerability

Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus.

Designer nanocarriers for navigating the systemic delivery of oncolytic viruses

Collaborators (7)

Penelope Ottewell

Aneurin James Kennerley

Sanjay K. Srivastava

Alan Graham Pockley

Magnus Essand

Richard Allen

Munitta Muthana

Make your next move.